ArticleBMC nephrology2021

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial.

Khoa Vu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.